These data, along with the findings at 30 weeks, suggest that hepatocyte-specific SAMHD1 deficiency alleviates liver steatosis, reduces lipid and cholesterol accumulation, and mitigates liver injury in the GAN diet-induced MASLD mouse model. The gene discussed is SAMHD1; the disease is Hepatic steatosis.